311 results on '"Nuccetelli, Marzia"'
Search Results
2. Circulating calprotectin as a potential biomarker of persistent olfactory dysfunctions in Post-COVID-19 patients
3. The potential role of interleukin-6 in the association between inflammation and cognitive performance in obstructive sleep apnea
4. CSF dynamics of orexin and β-amyloid42 levels in narcolepsy and Alzheimer’s disease patients: a controlled study
5. Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes
6. Autoantibody profiles assessment in individuals with persistent olfactory impairment following SARS-CoV-2 infection
7. Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19
8. 18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment
9. Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies
10. Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
11. Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
12. Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
13. Alteration of circadian sleep-wake rhythm and salivary melatonin secretion in idiopathic/isolated REM sleep behavior disorder: preliminary evidence
14. Constitutive NOS Production Is Modulated by Alzheimer’s Disease Pathology Depending on APOE Genotype
15. Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection
16. Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies
17. Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
18. A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2
19. The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
20. Circulating Calprotectin as a Potential Biomarker of Persistent Olfactory Dysfunctions in Post-COVID-19 Patients
21. SARS-CoV-2 infection serology: a useful tool to overcome lockdown?
22. Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
23. CSF biomarkers for predicting phenoconversion in patients with isolated REM sleep behaviour disorder
24. Uterine and placental blood flow indexes and antinuclear autoantibodies in unexplained recurrent pregnancy loss: should they be investigated in pregnancy as correlated potential factors? A retrospective study
25. Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder.
26. Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer’s Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer’s Disease Continuum
27. Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease
28. Amniotic fluid antiphospholipid antibodies: potential role in antiphospholipid syndrome-independent aberrant implantation process
29. Evaluation of the accuracy in the mucosal detection of anti-SARS-CoV-2 antibodies in nasal secretions and saliva
30. Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in Alzheimer's disease continuum
31. Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499
32. Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease
33. Evaluation of Hepcidin Level in COVID-19 Patients Admitted to the Intensive Care Unit
34. Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology
35. Conta differenziale leucocitaria e parametri morfometrici determinati con Mindray BC-6800 Plus: un possibile strumento predittivo per lo screening di sepsi.
36. Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time
37. Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer’s Disease Biomarkers
38. Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum.
39. Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine
40. Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test
41. Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution
42. Performance evaluation of the new Chemiluminescence Immunoassay CL-1200i Thyroid Panel
43. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
44. Aβ1–42 Detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible Aβ1–42 aggregation?
45. Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
46. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy
47. The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays
48. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence
49. 18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.
50. Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.